Why the study?
Does antihypertensive treatment attenuate progression in diabetic nephropathy?
Does antihypertensive treatment attenuate progression in diabetic nephropathy?
This review highlights the importance of early and aggressive blood pressure control, particularly with ACE inhibitors guided by proteinuria reduction, to attenuate the progression of diabetic nephropathy.
May support early aggressive BP control with ACEi guided by proteinuria in diabetic nephropathy; leaves open need for updated RCTs.
Ritz E, Rychlík I, Schömig M, Wagner J (Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany). Blood pressure in diabetic nephropathy – current controversies (Review). J Intern Med 2001; 249: 215–223. Hypertension has been recognized as an early and constant feature of diabetic nephropathy, but recent studies also suggest that a genetic predisposition to hypertension is an important risk factor for diabetic nephropathy. Antihypertensive treatment attenuates progression in diabetic nephropathy, but there is increasing evidence that very early treatment and very low target blood pressures should be implemented. There is also evidence for local activation of the renin system in the kidney as a result of hyperglycaemia. Apart from blood pressure, proteinuria should be monitored and dosing of ACE inhibitors should be guided, also by reduction of protein excretion.
No takes yet. Share an insight, caveat, or question.
Ritz et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: